Skip to main content
Premium Trial:

Request an Annual Quote

New Releases: May 13, 2009

Premium

Clinical Data's PGxHealth division announced this week that it is doubling the number of genes detected by its Familion Long QT Syndrome Test to 10 genes. The test helps guide treatment for sudden cardiac death.

The company also announced it has filed a patent application with the United States Patent and Trademark Office pertaining to 336 new mutations in the long QT genes.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.